The FDA Just Streamlined Tobacco Registration — Here’s Why Premium Cigar Consumers Should Still Pay Attention

On September 28, the U.S. Food and Drug Administration launched a redesigned Form FDA 3741, consolidating establishment registration and product listing into a single filing for every regulated tobacco product category. The redesigned form consolidates establishment registration and product listing submissions for all regulated tobacco product categories, including cigarettes, e-cigarettes, smokeless tobacco, heated tobacco products, and oral nicotine products such as nicotine pouches, replacing two previously separate forms — Form FDA 3741 and Form FDA 3741a — and is intended to simplify the process for manufacturers.

For most of the tobacco world, this is a routine administrative update. For premium cigars, it is a useful reminder of exactly where our industry stands — and why, though we are not regulated by the FDA, we cannot afford to ignore them entirely.

Here is the good news, and it is worth restating clearly: premium cigars are not on that list. They are not subject to Form FDA 3741, because, thanks to CRA’s leadership, they are no longer under FDA jurisdiction at all. In August 2023, Judge Amit P. Mehta vacated the FDA’s regulatory authority over premium cigars, and the D.C. Circuit Court of Appeals later affirmed that ruling, making it final earlier this year. That victory was the culmination of a decade of work. Cigar Rights of America led in that fight — challenging the FDA’s rulemaking process from 2016 forward, defending the ruling through appeal, and ensuring premium cigars were removed from the agency’s reach.

So when new registration requirements land on cigarette, vape, and nicotine-pouch manufacturers, premium cigar makers can rightly feel they are watching from the outside. That is the payoff of the Mehta decision.

But watching from the outside is not the same as being safe forever — and this is the part every consumer and retailer needs to remember. A court ruling, even one affirmed on appeal, is not the same as a statute. As CRA has explained, the FDA retains the theoretical ability to initiate a new rulemaking that could bring premium cigars back under its authority; while the current administration has taken a common-sense approach to tobacco regulation, a future administration with different priorities could attempt exactly that. Every routine FDA action, including a streamlined registration form, reminds us that the agency’s machinery for regulating tobacco is fully intact. Premium cigars simply sit outside it today. “Today” is the operative word.

That is precisely why the industry’s attention must stay fixed on securing a permanent, statutory exemption — and why H.R. 2111 matters. Our bill would statutorily exempt premium cigars from FDA regulation, taking the protection won through the Mehta decision and establishing it in federal law. A statute would close the door that a court ruling leaves ajar. It would make the premium cigar exemption a matter of congressional law rather than judicial interpretation, far harder for any single agency to undo.

At the center of both the court ruling and the bill is the Mehta Definition — the eight-part standard establishing that a premium cigar is wrapped in whole tobacco leaf, contains a 100 percent leaf tobacco binder, uses at least 50 percent long filler by weight, is handmade, has no filter or non-tobacco tip, carries no characterizing flavor other than tobacco, contains only tobacco, water, and vegetable gum, and weighs more than six pounds per thousand units. Its value lies in three things: a clean, material-based line between premium and mass-market products, the authority of a federal judge, and the absence of any price floor that would punish economically disadvantaged consumers or require constant amendment for inflation.

This is why a statutory definition is so important. A definition drawn on materials and craftsmanship — not price, not marketing category — is the only durable way to ensure that when regulators act on the rest of the tobacco market, premium cigars are cleanly and reliably excluded. Codifying the Mehta Definition through H.R. 2111 is how we turn a legal win into a lasting standard that lawmakers, regulators, businesses, and consumers can rely on for years to come.

The Mehta victory was more than a decade in the making. Making it permanent is the work that comes next — and every routine FDA update should sharpen, not soften, that resolve. CRA urges every enthusiast and retailer to sign the petition in support of H.R. 2111 and contact their representatives.